Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dornan David Insider Profile
4 Followers
Dornan David, CSO at Bolt Biotherapeutics, holds ― shares in Bolt Biotherapeutics (Ticker: BOLT), holds 5.22K shares in Elevation Oncology (Ticker: ELEV). Most recently, Dornan David ― shares of Bolt Biotherapeutics on ― for an estimated value of ―.
Dornan David has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Dornan David holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Dornan David
Dornan David's Trading History
Bolt Biotherapeutics
―
CSO
―
―
Elevation Oncology
Feb 19, 2025
CSO
Uninformative Buy
3.50K
$3.17K
List of latest transactions for each holding click on a transaction to see Dornan David's performance on stock
You May Also Like
Dornan David insider profile FAQ
What is the percentage of profitable transactions made by Dornan David?
The percentage of profitable transactions made by Dornan David is ―.
What is the average return per transaction made by Dornan David?
The average return per transaction made by Dornan David is ―.
What stocks does Dornan David hold?
Dornan David holds: BOLT, ELEV stocks.
What was Dornan David’s latest transaction?
Dornan David latest transaction was an Uninformative Buy of ―.
What was Dornan David's most profitable transaction?
Dornan David’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Dornan David's role in Bolt Biotherapeutics?
Dornan David's role in Bolt Biotherapeutics is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.